Sign in

CIK 0001936258 · Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
  1. 4 Planned sale Chief Scientific Officer sold 50,246 shares at $25.03 ($1,257,657)
  2. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $22.65 ($226,500)
  3. 4 Open-market sale Director sold 1,600 shares at $25.32 ($40,512)
  4. 4 Grant or award Vice President, Controller acquired 3,200 shares (grant or award)
  5. 4 Planned sale Chief Scientific Officer sold 125,000 shares at $26.91 ($3,363,750)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Planned sale Chief Accounting Officer sold 105,000 shares at an average $30.34 ($3,185,656)
  8. 4 Planned sale Chief Accounting Officer sold 40,000 shares at an average $30.20 ($1,208,159)
  9. 4 Planned sale Chief Accounting Officer sold 65,000 shares at $35.69 ($2,319,850)
  10. 4 Open-market sale Director sold 44,619 shares at an average $30.42 ($1,357,230)
  11. 4 Open-market sale Director sold 28,186 shares at $29.41 ($828,950)
  12. 4 Planned sale Chief Scientific Officer sold 300,000 shares at an average $30.30 ($9,090,868)
  13. 4 Open-market sale Chief Executive Officer sold 443,707 shares at $33.25 ($14,753,258)
  14. 4 Planned sale Chief Executive Officer sold 306,293 shares at an average $34.53 ($10,575,091)
  15. 4 Open-market sale Chief Scientific Officer sold 45,481 shares at an average $35.31 ($1,605,998)
  16. 4 Planned sale Chief Accounting Officer sold 72,428 shares at an average $32.25 ($2,335,860)
  17. 4 Planned sale Chief Accounting Officer sold 72,572 shares at an average $33.29 ($2,415,843)
  18. 4 Planned sale Chief Financial Officer sold 100,000 shares at an average $32.61 ($3,260,618)
  19. 4 Grant or award Director acquired 3,400 shares (grant or award)
  20. 4 Grant or award Director acquired 3,400 shares (grant or award)

Page 1 of 7 · 132 filings